Intrapatient competition of VEXAS syndrome and CML clones.

Autor: Djerbi N; Department of Medical Oncology and Hematology, University Hospital Zurich and University of Zurich, Zurich, Switzerland., Zimmermann K; Department of Medical Oncology and Hematology, University Hospital Zurich and University of Zurich, Zurich, Switzerland., Roncador M; Department of Medical Oncology and Hematology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.; Department of Biosystems Science and Engineering, Eidgenössische technische Hochschule Zurich, Basel, Switzerland., Becker MO; Department of Rheumatology, University Hospital Zurich and University of Zurich, Zurich, Switzerland., Manz MG; Department of Medical Oncology and Hematology, University Hospital Zurich and University of Zurich, Zurich, Switzerland., Balabanov S; Department of Medical Oncology and Hematology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
Jazyk: angličtina
Zdroj: Blood advances [Blood Adv] 2023 Nov 28; Vol. 7 (22), pp. 6815-6818.
DOI: 10.1182/bloodadvances.2023010814
Databáze: MEDLINE